Mechanistically, JMJD2D contributes to HSC activation and hepatic fibrosis progression by facilitating the transcription of toll-like receptor 4 (TLR4) through H3K9me2/3 demethylation, subsequently activating TLR4/NF-κB signaling in HSC [85]. Here, KDM4D is linked to Hepatic fibrosis.